Intuitive Surgical Stock Near Crucial Support – Buy Signal?
Intuitive Surgical (ISRG) stock should be on your watchlist. Here is why – it is currently trading in the support zone ($441.23 – $487.67), levels from which it has bounced meaningfully before. Since it first started trading, Intuitive Surgical stock received buying interest at this level 3 times and subsequently went on to generate 31.8% in average peak returns.
| Peak Return | Days to Peak Return | |
|---|---|---|
| 6/25/2024 | 38.0% | 211 |
| 4/7/2025 | 22.1% | 37 |
| 10/1/2025 | 35.3% | 97 |
Yet, a support zone alone isn’t enough; rebounds are more likely when fundamentals, sentiment, and market conditions line up. How does that look for ISRG?
Rebound likely, driven by robust sector growth.
Intuitive Surgical’s Q4 2025 performance exceeded expectations, fueled by 18% procedure growth and 81% recurring revenue. The robotic surgery market’s projected expansion to $27.1 billion by 2030, adoption of da Vinci 5, and increasing Ambulatory Surgery Center (ASC) penetration are strong tailwinds. While competitive pressures from Medtronic and an elevated valuation (P/E 58.43) persist, analyst targets average $615.50, implying significant upside. The stock’s recent decline and oversold RSI suggest a technical bounce, supported by sustained demand for its innovative platforms.
- Tired of AI and Oil? Buy the Robot.
- Better Value & Growth: PODD Leads Intuitive Surgical Stock
- Better Value & Growth: PODD Leads Intuitive Surgical Stock
- Stronger Bet Than Intuitive Surgical Stock: PODD Delivers More
- Pay Less, Gain More: PODD Tops Intuitive Surgical Stock
- Better Value & Growth: PODD Leads Intuitive Surgical Stock
How Do ISRG Financials Look Right Now?
- Revenue Growth: 20.5% LTM and 17.4% last 3-year average.
- Cash Generation: Nearly 24.7% free cash flow margin and 29.3% operating margin LTM.
- Recent Revenue Shocks: The minimum annual revenue growth in the last 3 years for ISRG was 14.5%.
- Valuation: ISRG stock trades at a PE multiple of 57.7
| ISRG | S&P Median | |
|---|---|---|
| Sector | Health Care | – |
| Industry | Health Care Equipment | – |
| PE Ratio | 57.7 | 23.9 |
|
|
||
| LTM* Revenue Growth | 20.5% | 6.8% |
| 3Y Average Annual Revenue Growth | 17.4% | 5.5% |
| Min Annual Revenue Growth Last 3Y | 14.5% | 0.4% |
|
|
||
| LTM* Operating Margin | 29.3% | 18.6% |
| 3Y Average Operating Margin | 27.4% | 18.1% |
| LTM* Free Cash Flow Margin | 24.7% | 14.2% |
*LTM: Last Twelve Months | For more details on ISRG fundamentals, read Buy or Sell ISRG Stock.
And What If The Support Breaks?
ISRG isn’t immune to big drops. It fell 82% during the Dot-Com Bubble and 76% in the Global Financial Crisis. The Inflation Shock saw nearly a 50% dip, and even the Covid sell-off wasn’t mild at 40%. The smaller 2018 correction still knocked it down 24%. So, no matter how strong a stock looks, sharp sell-offs can still hit hard.
But the risk is not limited to major market crashes. Stocks fall even when markets are in good shape – think events like earnings, business updates, outlook changes. Read ISRG Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.
Still not sure about ISRG stock? Consider the portfolio approach.
Portfolios Beat Stock Picking
Stocks soar and sink – the key is staying invested. A balanced portfolio helps you ride market volatility, boosts gains, and reduces single stock risk.
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? HQ Portfolio has posted more than 105% in cumulative return since inception, with less risk versus the benchmark index, as evident in HQ Portfolio performance metrics.